Independent information website. It does not replace a medical examination or advice.
Wegovy · semaglutide

Wegovy for weight management: semaglutide explained

Wegovy contains semaglutide and its injectable presentation is normally administered once weekly. It is authorised for weight management in defined groups alongside diet and physical activity.

Verified sourcesNo medicine salesA doctor decides

Semaglutide is a GLP‑1 receptor agonist. The injection dose is gradually increased to improve tolerability. Wegovy and Ozempic contain the same active substance, but they are different products with different authorised uses.

What to know

What to know

01

Do not use Ozempic as a self-selected substitute for Wegovy.

02

Digestive adverse effects are common during initiation and dose escalation.

03

A sudden loss or rapid worsening of vision requires prompt medical attention.

What a doctor assesses

What a doctor assesses

A medicine is selected only after an individual medical assessment. BMI is one part of the decision, not the decision itself.

  • BMI, waist circumference and weight history
  • Related conditions and recent test results
  • Current medicines, allergies and contraindications
  • Previous treatment, goals and ability to attend follow-up
Safety and responsible access

Safety and responsible access

Prescription weight-management medicines can cause adverse effects and are not suitable for everyone. The exact risks, dose escalation and monitoring differ by product. Read the current package leaflet and contact a doctor or pharmacist if anything is unclear.

FAQ

Questions about this topic

Are Wegovy and Ozempic the same medicine?+

They contain semaglutide, but their authorised uses, doses and product information differ. They should not be substituted without a prescriber’s decision.

Can I decide from this page whether the treatment is suitable for me?+

No. This page is educational. A licensed doctor must consider your history, other medicines, contraindications and local product information.

Official sources

Official sources

EMA · WegovyOpen official informationEMA · semaglutide and NAIONOpen official informationEuropean Medicines AgencyOpen official informationYour Europe · cross-border prescriptionsOpen official information

Sources reviewed 12 August 2026.